Prevalence of Parvovirus B19 Specific Antibody in Pregnant Women with Spontaneous Abortion

  • Nahid Rahbar Research Center of Abnormal Uterine Bleeding and Semnan University of Medical Sciences, Semnan, Iran.
  • Saeid Vali Zadeh Mail Department of Virology and Bacteriology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
  • Raheb Ghorbani Research Center for Social Determinates of Health, Semnan University of Medical Sciences, Semnan, Iran.
  • Pegah Kheradmand Department of Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Keywords:
Human Parvovirus B19, Spontaneous abortion, Immunoglobulin M, Pregnancy

Abstract

Human parvovirus B19 is a very common viral infection especially in school-aged children. The infection during pregnancy can affect the fetus due to lack of mother's immunity. Although, there is still no evidence of fetal teratogenic effects with parvovirus B19, but non-immune fetal hydrops and abortion may be caused by vertical transmission of the virus during pregnancy. This study was aimed to assess the prevalence of parvovirus B19-specific antibody (IgM) in pregnant women who had a spontaneous abortion. This cross-sectional study was carried out in all pregnant women who referred due to a spontaneous abortion. All demographic information such as age, occupation, and gestational age, last history of abortion, gravity, and presence of children below the age of six was recorded and a blood sample was provided for all the women. Then, the blood samples were tested to assay parvovirus B19-specific antibody (IgM) by EuroImmune ELISA kit. Among 94 pregnant women with the mean age of 28.4 years who had a spontaneous abortion, parvovirus B19 specific antibody (IgM) was detected in 17 participants (18.1%). Meanwhile, 14 women (14.9%) were suspected for presence of the antibody in their blood sample. There was no significant difference between the presence of antibody and age of pregnant women, occupation, gestational age, number of previous abortion, presence of children below the age of six and number of pregnancy. These findings revealed that a high percentage of pregnant women are probably non-immune against parvovirus B19, and also there might be a number of spontaneous abortions in which parvovirus infection caused fetal death.  However, more studies are needed to prove the absolute role of parvovirus B19 in these abortions.

References

Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet 1975;1(7898):72-3.

Lunardi C, Tinazzi E, Bason C, et al. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 2008;8(2):116-20.

Enders M, Weidner A, Zoellner I, et al. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24(7):513-8.

Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence, and fetal prognosis. Pediatr Infect Dis J 2002;21(12):1133-6.

De Haan TR OD, Beersma MFC, Walther FJ. Aetiology, diagnosis and treatment of hydrops foetalis. Curr Pediatr Rev 2005;1(1):63-72.

Jordan JA, De Loia JA. Globoside expression within the human placenta. Placenta 1999;20(1):103-8.

el-Sayed Zaki M, Goda H. Relevance of parvovirus B19, Herpes Simplex Virus2, and Cytomegalovirus Virologic Markers in Maternal Serum for Diagnosis of Unexplained Recurrent Abortions. Arch Pathol Lab Med 2007;131(6):956-9.

Cunninghham FG, Leveno KJ, Bloom SL, et al, editors. Williams OBSTETRICS. 23rd ed. New York: Mac Grow Hill; 2010: p. 1207-19.

Bosman A, Wallinga J, Kroes AMC. Fifth disease every four◦years: parvovirus B19. Infectieziekten Bul 2002;13:215-9.

Lamont, RF, Sobel JD, Vaisbuch E, et al. Parvovirus B19 infection in human pregnancy. BJOG 2010;118(2):175-86.

Pattison JR. Human parvovirus B19 Hard to differentiate from infectious mononucleosis. BMJ 1994;308(6928):595.

Cohen B. Parvovirus B19: an expanding spectrum of disease. BMJ 1995;311(7019):1549-52.

Miller E, Fairley CK, Cohen BJ, et al. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105(2):174-8.

Prospective study of human parvovirus (B19) infection in pregnancy.Public Health aboratory Service Working Party on Fifth Disease. Br Med J 1990;300(6733):1166-70.

Yaegashi N, Niinuma T, Chisaka H, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 1998;37(1):28-35.

Brown T, Anand A, Ritchie LD, et al. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984;2(8410):1033-4.

Porter HJ, Khong TY, Evans MF, et al. Parvovirus as a cause of hydrops fetalis: detection by in situ DNA= hybridisation. J Clin Pathol 1988;41(4):381-3.

Jordan JA. Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol 1996;174(1 Pt 1):37-42.

Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. J Am Med Assoc 1999;281(12):1099-105.

Mossong J, Hens N, Friederichs V, et al. Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection. Epidemiol Infect 2008;136(8):1059-68.

Sohrabi A, Samarbafzadeh AR, Makvandi M, et al. A seroepidemiological study of Parvovirus B19, Toxoplasma gondii and Chlamydia trachomatis in pregnant women referring to Obs & Gyn ward of Ahwaz Imam Khomeini Hospital. J Reprod Infertil 2008;31(2):171-5.

Shahraki S, Moradi A, Ebrahimi-Tabas A, et al. B19 Parvovirus In 15-45 Year-Old Women In Saravan In 2001. ZUMS J 2003;11(44);37-40.

Ziyaeyan M, Rasouli M, Alborzi A. The Seroprevalence of Parvovirus B19 infection amang To-Be-Married girls, pregnant women, and Their Neonates in Shiraz, Iran. Jpn J Infect Dis 2005;58(2):95-7.

Mirzaie F, Arab-Zadeh SAM, Jeihuni Sh, et al. Comparison of the Frequency of CMV and Parvo B19 Infections in Intrauterin Fetal Death and Normal Pregnancy. KMUS J 2008;15(4):273-81.

Riipinen A, Vaisanen E, Nuutila M, et al. Parvovirus B19 Infection in fetal Deaths. Clin Infect Dis 2008;47(12):1519-25.

Nyman M, Tolfvenstam T, Petesson K, et al. Detection of human Parvovirus B19 Infection in First-Trimester fetal Loss. Obstet Gynecol 2002;99(5 Pt 1):795-8.

Elnifro E, Nisha AK, Almabsoot M, et al. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. J Infect Developing Countries 2009;3(3):218-20.

Maksheed M, Pacsa AS, Essa S, et al. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait. Acta Trop 1999;73(3):225-9.

Barros De Freitas R, Buarque De Gusmão SR, Durigon EL, et al. Survey of parvovirus B19 Infection in a Cohort of Pregnant Woman in Belem, Brazil. Braz J Infect Dis 1999;3(1):6-14.

Goldenberg RL, Thompson C. The infectious origins of stillbirth. Am J Obstet Gynecol 2003;189(3):861-73.

Jensen I, Thorsen P, Jeune BR, et al. Vestergaard: An epidemic of parvovirus B19 in a population of 3596 pregnant Woman: a study of sociodemographic and medical risk factors. BJOG 2000;107(5):637-43.

How to Cite
1.
Rahbar N, Vali Zadeh S, Ghorbani R, Kheradmand P. Prevalence of Parvovirus B19 Specific Antibody in Pregnant Women with Spontaneous Abortion. Acta Med Iran. 53(3):168-172.
QRcode
Section
Articles